APO TP 25 (Topiramate 25 mg)
Pill imprint APO TP 25 has been identified as Topiramate 25 mg.
Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; bulimia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO TP 25
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2760
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
magnesium stearate
methylcellulose (15 mPa.s)
polyethylene glycol 8000
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0769 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about topiramate
Consumer resources
- Topiramate
- Topiramate extended-release capsules
- Topiramate sprinkle capsules
- Topiramate (Advanced Reading)
- Other brands: Topamax, Trokendi XR, Topiragen, Topamax Sprinkle, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
